Back to top

Cytori Therapeutics (CYTX) Soars: Stock Adds 11.4% in Session
January 09, 2014

Read MoreHide Full Article
Cytori Therapeutics, Inc. (CYTX - Free Report) was a big mover last session, as the company saw its shares rise by over 11% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company as the stock has now gained over 31% since Dec 16.

This biotechnology company has seen no estimate revision over the past 30 days and its Zacks Consensus Estimate remained unchanged over the same time frame. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Cytori Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the same industry include Affymetrix Inc. , Alimera Sciences, Inc. (ALIM - Free Report) and Genomic Health Inc. (GHDX - Free Report) . All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Cytori Therapeutics Inc (CYTX) - free report >>

Alimera Sciences, Inc. (ALIM) - free report >>

Genomic Health, Inc. (GHDX) - free report >>

You May Like